Pharmacogenomics Market To Cross $10,505.3 Million Value by 2030, says P&S Intelligence

/PRNewswire/ -- In 2021, the global pharmacogenomics market was worth $5,527.2 million, which is set to reach $10,505.3 million, rising at a CAGR of 7.4% from...

Related Keywords

Mexico ,Germany ,United States ,Brazil ,Saudi Arabia ,South Africa ,Canada ,France ,America ,Prajneesh Kumar ,Roche Ltd ,Me Inc ,Laboratory Corporation Of America Holdings ,Foundation Medicine Inc ,Admera Health ,Research Organizations ,Genetics Inc ,Mesa Laboratories Inc ,Thermo Fisher Scientific Inc ,United States Clinical Laboratory Improvement Amendments ,Abbott Laboratories ,Sciences Corporation ,Hoffmann La Roche Ltd ,Myriad Genetics Inc ,Laboratory Corporation ,America Holdings ,Exact Sciences Corporation ,Mesa Laboratories ,Pharmacogenomics Market ,North America ,Foundation Medicine ,Thermo Fisher Scientific ,Seqstudio Flex Series Genetic Analyzer ,Pharmacogenomics Market Size ,Demand Forecast Through ,Chain Reaction ,P Amps Intelligence ,